Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
The price of Progyny Inc (NASDAQ: PGNY) closed at $14.71 in the last session, up 1.24% from day before closing price of $14.53. In other words, the price has increased by $1.24 from its previous closing price. On the day, 1.46 million shares were traded. PGNY stock price reached its highest trading level at $14.81 during the session, while it also had its lowest trading level at $14.3183.
Ratios:
We take a closer look at PGNY’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 5.31 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 7.81. For the most recent quarter (mrq), Quick Ratio is recorded 2.62 and its Current Ratio is at 2.62. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.04.
On November 13, 2024, Truist Downgraded its rating to Hold which previously was Buy and also lowered its target price recommendation from $26 to $19.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Dec 26 ’24 when Schlanger David J bought 150,000 shares for $14.68 per share. The transaction valued at 2,202,330 led to the insider holds 228,269 shares of the business.
Anevski Peter bought 209,500 shares of PGNY for $3,034,084 on Dec 23 ’24. The CHIEF EXECUTIVE OFFICER now owns 441,463 shares after completing the transaction at $14.48 per share. On Dec 09 ’24, another insider, SEIDENBERG BETH C, who serves as the Director of the company, bought 39,680 shares for $15.82 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PGNY now has a Market Capitalization of 1252604928 and an Enterprise Value of 1004874880. As of this moment, Progyny’s Price-to-Earnings (P/E) ratio for their current fiscal year is 25.34, and their Forward P/E ratio for the next fiscal year is 24.72. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.68. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.10 while its Price-to-Book (P/B) ratio in mrq is 2.99. Its current Enterprise Value per Revenue stands at 0.882 whereas that against EBITDA is 14.689.
Stock Price History:
Over the past 52 weeks, PGNY has reached a high of $42.08, while it has fallen to a 52-week low of $13.39. The 50-Day Moving Average of the stock is -3.81%, while the 200-Day Moving Average is calculated to be -38.92%.
Shares Statistics:
According to the various share statistics, PGNY traded on average about 1.71M shares per day over the past 3-months and 1886870 shares per day over the past 10 days. A total of 88.34M shares are outstanding, with a floating share count of 71.52M. Insiders hold about 16.01% of the company’s shares, while institutions hold 91.55% stake in the company. Shares short for PGNY as of 1732838400 were 11406564 with a Short Ratio of 7.12, compared to 1730332800 on 11154209. Therefore, it implies a Short% of Shares Outstanding of 11406564 and a Short% of Float of 16.98.
